Insider Transactions in Q2 2021 at Biocryst Pharmaceuticals Inc (BCRX)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 10
2021
|
Nancy J Hutson Director |
SELL
Open market or private sale
|
Direct |
23,333
-26.39%
|
$373,328
$16.86 P/Share
|
|
Jun 10
2021
|
Nancy J Hutson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
23,333
+12.35%
|
$69,999
$3.09 P/Share
|
|
May 28
2021
|
Steve Aselage Director |
BUY
Grant, award, or other acquisition
|
Direct |
634
+1.94%
|
$9,510
$15.77 P/Share
|
|
May 28
2021
|
Theresa Heggie Director |
BUY
Grant, award, or other acquisition
|
Direct |
317
+2.19%
|
$4,755
$15.77 P/Share
|
|
May 28
2021
|
Nancy J Hutson Director |
BUY
Grant, award, or other acquisition
|
Direct |
317
+0.48%
|
$4,755
$15.77 P/Share
|
|
May 28
2021
|
Robert Alexander Ingram Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,188
+1.54%
|
$17,820
$15.77 P/Share
|
|
May 28
2021
|
William P Sheridan Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
91,814
-86.38%
|
$1,377,210
$15.02 P/Share
|
|
May 28
2021
|
William P Sheridan Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
91,814
+27.25%
|
$459,070
$5.26 P/Share
|
|
May 27
2021
|
William P Sheridan Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
71,759
-83.21%
|
$1,076,385
$15.0 P/Share
|
|
May 27
2021
|
William P Sheridan Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
71,759
+27.46%
|
$358,795
$5.26 P/Share
|
|
May 24
2021
|
George B Abercrombie Director |
SELL
Open market or private sale
|
Direct |
6,667
-68.97%
|
$86,671
$13.9 P/Share
|
|
May 24
2021
|
George B Abercrombie Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,667
+40.82%
|
$13,334
$2.63 P/Share
|
|
May 12
2021
|
Alane P Barnes Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
35,852
+19.7%
|
$143,408
$4.73 P/Share
|
|
May 11
2021
|
Alane P Barnes Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
102,780
-48.24%
|
$1,233,360
$12.04 P/Share
|
|
May 11
2021
|
Alane P Barnes Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
102,780
+14.75%
|
$308,340
$3.87 P/Share
|
|
May 10
2021
|
George B Abercrombie Director |
SELL
Open market or private sale
|
Direct |
7,000
-70.0%
|
$84,000
$12.7 P/Share
|